Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

AMULET BRINGS ELITE PERFORMANCE TO WOMEN'S HORMONAL HEALTH -- BACKED BY INVESTORS INCLUDING MARIA SHARAPOVA AND GABRIELA HEARST

Amulet Logo

News provided by

Amulet

Apr 13, 2026, 10:02 ET

Share this article

Share toX

Share this article

Share toX

Science-backed brand introduces the first "female performance" platform designed to help women experience more good days each month

NEW YORK, April 13, 2026 /PRNewswire/ -- A new chapter in women's health begins with the launch of Amulet, a science-backed hormonal health company designed to help women perform at their best every day, through every phase.

The brand debuts with Daily Cycle Support, a biotechnology-powered supplement designed to support hormonal balance for women and promote energy, mood, strength, and cognitive performance throughout the entire menstrual cycle.

Continue Reading
Amulet's flagship product: Daily Cycle Support.
Amulet's flagship product: Daily Cycle Support.

Amulet, a Squared Circles company, is led by CEO Suzanne Stockbridge, a seasoned consumer health executive with experience scaling science-backed brands, and formerly GM of Oddity's SpoiledChild.

"For too long, women's health solutions have been reactive, fragmented, and narrowly focused on symptom relief," said Suzanne Stockbridge, CEO of Amulet. "Amulet was built around a different vision: helping women perform more consistently across their entire cycle. Starting with Daily Cycle Support, we're creating a platform designed to give women more good days every month."

A Broken Category Ready for Reinvention
Despite hormones influencing nearly every aspect of women's physical and mental performance (from mood and metabolism to strength and cognitive focus) most solutions in the market remain limited to period relief.

The result is a massive gap in women's health.

Consumer research conducted by Squared Circles suggests that many women experience only around 10 truly optimal days per month due to natural hormonal fluctuations, yet are expected to perform consistently across work, training, relationships, and life.

Meanwhile, the current market is dominated by products that fall into two categories:

  • Pharmaceutical interventions, such as birth control or pain medication
  • "Pink-washed" wellness products built around herbal blends with limited clinical validation

Amulet was created to offer a third path: science-backed performance support built specifically for women's biology.

The company's mission is simple but ambitious: help women experience more good days each month by stabilizing the biological fluctuations that affect performance.

This comes at a time when women's health is undergoing a cultural shift. Across medicine, athletics, and wellness, a new generation of women is seeking tools that help them work with their biology—not against it. Amulet is at the forefront of this shift, building a brand designed not around "period care," but around female performance.

A Breakthrough Formula Built for Female Biology
Amulet's flagship product, Daily Cycle Support, is formulated with two bio-identical active ingredients backed by extensive scientific research: lactoferrin and creatine. Together, these ingredients are designed to work in sync with the body's estrogen-driven hormonal rhythms. Because both lactoferrin expression and creatine metabolism are estrogen-responsive, targeted supplementation may help support more consistent performance throughout the menstrual cycle.

Amulet spent over a year developing Daily Cycle Support as a delicious, easy-to-take gummy, with a focus on convenience, safety, and efficacy at clinically-studied dosages. The formula is rigorously third-party tested to ensure quality and consistency.

Emerging research also suggests potential synergistic benefits from this novel ingredient combination, including support for muscle health and energy. Amulet will continue to invest in women's health research to further advance and validate these findings.

effera® Bio-Identical Lactoferrin

Amulet's groundbreaking formulation features effera® bio-identical lactoferrin, a powerful bioactive protein naturally found in the female reproductive tract and in breast milk.

Unlike cow lactoferrin, which is traditionally used in supplements, Amulet's formulation uses effera®, a precision-fermented, bio-identical lactoferrin developed by Helaina™, a New York-based biotechnology company advancing human nutrition. This bio-identical lactoferrin mirrors native human lactoferrin, maximizing utilization while minimizing inflammatory responses.

Lactoferrin supports key aspects of women's health, targeting:

  • menstrual health
  • iron regulation
  • immune defense
  • gut and vaginal microbiome balance
  • inflammatory response
  • hair and skin health
  • sustained energy and mood

"We're incredibly excited to support Amulet's launch and its vision to help women live better lives. It reflects a broader shift in our industry—from using ingredients that were simply available to creating ones like effera® that are designed to match women's biology," said Laura Katz, Founder & CEO, Helaina.

Creatine

The formulation also includes creatine monohydrate, one of the most extensively studied compounds in sports and cognitive performance science.

While often associated with male athletes, the role of creatine in women's hormonal health has been largely ignored until now. Research also shows women typically have 70–80% lower creatine stores than men, meaning supplementation can be even more impactful for women, supporting:

  • menstrual health
  • energy production
  • muscle strength and recovery
  • cognitive performance
  • mood stability

Maria Sharapova Joins as Investor and Strategic Advisor
Tennis champion, entrepreneur, and investor Maria Sharapova has joined Amulet as both an investor and strategic advisor.

Sharapova brings the perspective of one of the world's most accomplished female athletes, having experienced firsthand how hormonal fluctuations can influence performance and recovery.

"Throughout my career I was expected to perform no matter what time of the month it was, and there wasn't any conversation about how our cycles affect how we feel, train, and show up every day," said Sharapova. "That's one of the reasons I connected with Amulet. It's designed to support women throughout their entire cycle, not just a few days each month."

Built on Scientific Leadership
Amulet's scientific advisory board includes leading experts in women's health, endocrinology, and nutrition.

Among them is Dr. Stephanie Kuku, member of the Royal College of Obstetricians & Gynaecologists, specialist in women's health, and honorary senior research fellow at the UCL Institute of Women's Health.

"Women's physiology is dynamic and cyclical, yet most health products ignore this fundamental biological reality," said Dr. Kuku. "Amulet is built around a deeper understanding of hormonal biology and uses evidence-based ingredients to help stabilize fluctuations that influence mood, energy, and performance."

About Amulet
Amulet is a women's health company focused on cycle support and female performance. Developed with leading doctors, scientists, and nutritionists, Amulet creates science-backed solutions designed to stabilize hormonal fluctuations and help women experience more "good days" every month.

Media Contact:
[email protected]
Website:
www.tryamulet.com

About Squared Circles
Squared Circles is the consumer health venture studio partnered with L Catterton that builds category-defining brands at the intersection of health, performance, and longevity, including Magic Molecule, Freaks of Nature, Algae Cooking Club, and SwimClub.

About Helaina
Helaina is a biotechnology company producing human-equivalent bioactive proteins through precision fermentation. Its flagship ingredient, effera® human lactoferrin, mirrors the immune and nutritional properties of the protein found in human milk. Helaina is redefining what nutrition can do through safe, scalable, and human-specific ingredients.

Learn more at www.myhelaina.com

SOURCE Amulet

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.